journal cover

Maternal insulin to lower the risk of fetal macrosomia in diabetic pregnancy

Clinical Obstetrics and Gynecology

Jun 1, 1991

D R Coustan

Abstract

Fetal macrosomia is a well-recognized adverse outcome associated with gestational diabetes. Weekly measurement of fasting and postprandial glucose should identify those with fasting (greater than or equal to 100 or 105 mg/dl) or postprandial (greater than or equal to 120 mg/dl 2 hours a...read more

Mentioned in this Paper

Pregnancy in Diabetics
Gestational Diabetes
Insulin B Chain
Novolin
Drugs used in migraine prophylaxis
Fetal Macrosomia
Hyperglycemia
Dextranase Activity
Prophylactic Behavior
Blood Glucose

Maternal insulin to lower the risk of fetal macrosomia in diabetic pregnancy

Clinical Obstetrics and Gynecology

Jun 1, 1991

D R Coustan

PMID: 1868636

DOI: 10.1097/00003081-199106000-00009

Abstract

Fetal macrosomia is a well-recognized adverse outcome associated with gestational diabetes. Weekly measurement of fasting and postprandial glucose should identify those with fasting (greater than or equal to 100 or 105 mg/dl) or postprandial (greater than or equal to 120 mg/dl 2 hours a...read more

Mentioned in this Paper

Pregnancy in Diabetics
Gestational Diabetes
Insulin B Chain
Novolin
Drugs used in migraine prophylaxis
Fetal Macrosomia
Hyperglycemia
Dextranase Activity
Prophylactic Behavior
Blood Glucose

Related Papers

/papers/maternal-insulin-to-lower-the-risk-of-fetal/1868636